Advisor Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Advisor Group’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,400	Closed	–	–	5244
2018 Q1	$0	Sell	1,400 -32	-2%	-$30	﹤0.01%	5262
2017 Q4	$2K	Hold	1,432	–	–	﹤0.01%	4775
2017 Q3	$3K	Hold	1,432	–	–	﹤0.01%	4508
2017 Q2	$4K	Hold	1,432	–	–	﹤0.01%	4384
2017 Q1	$5K	Sell	1,432 -1,200	-46%	-$4.74K	﹤0.01%	4170
2016 Q4	$5K	Sell	2,632 -100	-4%	-$235	﹤0.01%	3985
2016 Q3	$9K	Sell	2,732 -1	-0%	-$4	﹤0.01%	3659
2016 Q2	$11K	Buy	+2,733	New	+$12.4K	﹤0.01%	3462

Other funds holding OREX

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Advisor Group's OREX Position: Q2 2018 in Review

Advisor Group sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 1,400 shares.

Advisor Group first reported a position in OREX in Q2 2016 and held it in 8 quarters. The position peaked at $11K in Q2 2016. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

Advisor Group reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Advisor Group sold 1,400 Orexigen Therapeutics, Inc. shares in Q2 2018.
Advisor Group first reported a position in Orexigen Therapeutics, Inc. in Q2 2016 and held it in 8 quarters.
Advisor Group's Orexigen Therapeutics, Inc. position peaked at $11K in Q2 2016.
4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Advisor Group's 13F filing for Q2 2018, filed 13 Aug 2018.